• US: +1 9176726599
  • Login

Global Bioelectric Medicine Market Revenue To Scale Up To Highest Peak With US$22,800.9 Million By 2027

Published date - 17/04/2022

October 2021 | Report Format: Electronic (PDF)

Factors such as an increase in the number of chronic diseases and a rise in the global elderly population have resulted in increased adoption of innovative and novel treatment devices, which is likely to drive the bioelectric medicine market's growth. The advancements in electroceutical device technology, as well as the adoption of collaboration and mergers and acquisitions among companies, are increasing the possibility for the bioelectric medicine market to develop.

The elderly are at a higher risk of having neurologic or cardiovascular problems. Geriatrics are a major part of the entire patient pool because of their greater vulnerability to such diseases. As a consequence, the continued and increased demand for such as implantable cardioverter defibrillators, cardiac pacemakers, spinal cord stimulators, and deep brain stimulators for the treatment of cardiovascular and neurological disorders will be ensured by the growth of this population segment.

On the basis of type, the electroceuticals market is divided into implanted electroceutical devices and non-invasive electroceutical devices. The implanted electroceutical devices sector was the most popular in 2020. The growth of this category is being fueled by factors such as the growing prevalence of neurological and cardiovascular diseases, as well as a rise in the number of product approvals.

Request a Free Sample Copy: Bioelectric Medicine Market Report

Bioelectric Medicine Market Report Highlights

  • Rise in new approvals for advanced bioelectric medicine and increase in investment and funding for the development of new therapies and electroceuticals is expected to rise the growth for bioelectric medicine market.
  • However, factors such as stringent government rules and regulations for development and manufacture of new devices, product recalls, high price of cochlear implantation and lack of skilled professionals are expected to hamper the growth for bioelectric medicine market during the forecast period
  • In April 2019, ReShape Lifesciences Inc. announced that company has successfully implanted its first patient in the ENDURE II trial to support CE Marking of the ReShape Vest to treat obesity and metabolic diseases where the clinical results show 85% excess weight loss at one year.

BIOELECTRIC MEDICINE MARKET SEGMENTATION

The research report published by Market Research Strategy contains industry segments, as below-

Bioelectric Medicine Product Outlook (Revenue, USD Million, 2016 - 2027)

  • Cardiac Pacemakers & Implantable Cardioverter Defibrillators
  • Spinal Cord Stimulators
  • Cochlear Implants
  • Deep Brain Stimulators
  • Sacral Nerve Stimulators & Gastric Electrical Stimulators
  • Transcutaneous Electrical Nerve Stimulators
  • Vagus Nerve Stimulators
  • Other 

Bioelectric Medicine Type Outlook (Revenue, USD Million, 2016 - 2027)

  • Implantable Bioelectric medicine Devices
  • Noninvasive Bioelectric medicine Devices

Bioelectric Medicine End-users Outlook (Revenue, USD Million, 2016 - 2027)

  • Hospitals
  • Research Institutes
  • Individual Users
  • Others

Bioelectric Medicine Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America (U.S., and Canada)
  • Europe (Germany, U.K., France, Italy, Spain etc.)
  • Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
  • South America (Brazil, Mexico, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa etc.)

List of Key Players of Bioelectric Medicine Market

  • Vomaris Innovations, Inc.
  • Stimwave LLC
  • St. Jude Medical
  • Sonova Holding AG
  • Second Sight Medical Products, Inc.
  • Oticon Medical
  • Nevro Corporation
  • NeuroSigma, Inc.
  • Medtronic plc.
  • MED-EL
  • LivaNova PLC
  • EnteroMedics Inc.
  • ElectroCore LLC
  • Cochlear Limited
  • Cefaly Technology
  • Boston Scientific Corporation
  • Biotronik
  • BioElectronics Corporation

About Market Research Strategy:

Market Research Strategy (MRS) is a dedicated and disciplined market research firm that delivers authentic consulting services with accurate data forecasting for research-related services. The positive and result-oriented approaches implemented by us are beneficial in identifying the market challenges of any brand or start-up company to penetrate the competitive business space.

MRS also supports numerous organizations with its syndicate data and research reports to establish and survive in the market by grabbing the available market opportunities. Our vast experience and huge client database turn out to be our wealth and also secures our market position at the top of the list. Besides, we make use of every single piece of information, mined from authentic sources, into a valuable asset of the report; aiding our clients with informed business decisions.

Contact Us:

Market Research Strategy

473 Mundet Place,

Ste US520501 Hillside

New Jersey 07205 United States

USA Phone: ++1 9176726599

Business Email: sales@marketresearchstrategy.com

Website: https://marketresearchstrategy.com/

Copyright © 2022 Market Research Strategy, All rights reserved.